Muhammad Essa: Comparing Indobufen and Aspirin in Acute Ischemic Stroke
Muhammad Essa, Coordinator at IIMC Literary and Debating Society, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical Neuropharmacology, adding:
”A year ago i didn’t know what a meta analysis was.
Today I have multiple abstracts accepted at international conferences and I’m delighted to share that our research article, ‘Indobufen Versus Aspirin in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis,’ has been published in Clinical Neuropharmacology (Lippincott, Wolters Kluwer). Alhamdulillah.
This publication holds a particularly special place in my heart.
Being one of the first research projects I worked on, it gave me the opportunity to contribute to different stages from literature screening and data extraction to statistical analysis and manuscript preparation.
I am especially grateful to Ahmad Hassan for his invaluable mentorship, guidance, and encouragement throughout this journey.
A heartfelt thank you to all my co-authors for their contributions and for making this work possible.
Key Findings
Our systematic review and meta-analysis suggests that indobufen may offer comparable efficacy to aspirin, with better functional outcomes and a lower risk of short-term bleeding.”
Title: Indobufen Versus Aspirin in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Authors: Ahmad Hassan, Muhammad Rayyan Yousafi, Muhammad Essa, Affaf Mahmood, Ahmed Asif, Muhammad Sarmad, Usama Ahmad, Amna Iman, Semil Saleem, Kanza Raees, Maria Sreena, Ubaid Ur Rehman, Maaz Amir, Hanzalah Bin Arshad, Maryam Saqib, Abdul Haseeb Hasan
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 7, 2026, 16:42Inderpaul Birdi: Warfarin or Newer Blood Thinners?
-
Nov 7, 2026, 16:31Arwa Z. Al-Riyami: EMR Transfusion Medicine Featured in October 2026 Issue of ISBT Transfusion Today
-
Nov 7, 2026, 16:31Rafael Gomes: Is Dual Antiplatelet Therapy Still Necessary After LAAO?
-
Nov 7, 2026, 16:15Mazyar Shadman: Novel BTK Inhibitors and DOACs A Multicenter Study of Bleeding Risk
-
Nov 7, 2026, 15:54Hassan Raza: Beyond the 100 Minus Age Rule in Bone Marrow Cellularity
-
Nov 7, 2026, 15:42Andrew Zapfel։ Advancing Sickle Cell Disease Care Through Training, Advocacy and Collaboration
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation